44 parallel-processing-bioinformatics-"Multiple" Postdoctoral positions at KINGS COLLEGE LONDON in United Kingdom
Sort by
Refine Your Search
-
. This document will provide information of what criteria will be assessed at each stage of the recruitment process. Please note that this is a PhD level role but candidates who have submitted their thesis and are
-
tissue samples from one of Europe’s largest and most well- characterised ILD cohorts. The postholder will be responsible for tissue processing ad generation of / sorting of primary lung cells from
-
“Apply Now”. This document will provide information of what criteria will be assessed at each stage of the recruitment process. * Please note that this is a PhD level role but candidates who have submitted
-
at each stage of the recruitment process. We pride ourselves on being inclusive and welcoming. We embrace diversity and want everyone to feel that they belong and are connected to others in our community
-
of the recruitment process. Please note that this is a PhD level role but candidates who have submitted their thesis and are awaiting award of their PhDs will be considered. In these circumstances the appointment will
-
of what criteria will be assessed at each stage of the recruitment process. Further information: We pride ourselves on being inclusive and welcoming. We embrace diversity and want everyone to feel
-
at the bottom of the next page after you click “Apply Now”. This document will provide information of what criteria will be assessed at each stage of the recruitment process. * Please note that this is a PhD
-
. This document will provide information of what criteria will be assessed at each stage of the recruitment process. * Please note that this is a PhD level role but candidates who have submitted their thesis and
-
of interest in this area include, but are not limited to: natural language processing, large language models, graph learning, general pre-trained transformers, prompt engineering, knowledge graphs, knowledge
-
that undermine antimicrobial efficacy. One major driver of resistance is the repeated use of antibiotics to treat relapsing infections. In such cases, antibiotics initially appear to clear the infection, but it